Form 4 for MGNX MACROGENICS INC
Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-07 · accession 0001125345-25-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-11 | 2025-02-08 | MGNX | Peters Jeffrey Stuart | GC, Senior VP | F - Tax | $2.60 | -3,475 | 5,526 | -39% | -$9,035 |
| D | 2025-02-11 | 2025-02-08 | MGNX | Peters Jeffrey Stuart | GC, Senior VP | M - OptEx | — | +9,001 | 9,001 | New | — |
| D | 2025-02-11 | 2025-02-08 | MGNX | Peters Jeffrey Stuart | GC, Senior VP | M - OptEx | $0.00 | -9,001 | 18.0K | -33% | $0 |
| DM | 2025-02-11 | 2025-02-07 | MGNX | Peters Jeffrey Stuart | GC, Senior VP | A - Grant | $0.00 | +123.0K | 18.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-08 | F | D | 3,475 | $2.60 | 5,526 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-08 | M | A | 9,001 | — | 9,001 | D | — | — | (F1) On February 8, 2024, the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Unit | 2025-02-08 | M | D | 9,001 | $0.00 | 17,999 | D | — · — to — | 9,001 Common Stock | (F1) On February 8, 2024, the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2025-02-07 | A | A | 105,000 | $0.00 | 105,000 | D | $2.60 · — to 2035-02-07 | 105,000 Common Stock | (F2) 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. |
| 5 | Derivative | Restricted Stock Unit | 2025-02-07 | A | A | 18,000 | $0.00 | 18,000 | D | — · — to — | 18,000 Common Stock | (F3) Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. |